Merck KGaA agreed to buy SpringWorks Therapeutics Inc., a maker of medicines for cancer and rare diseases, to boost its ...

Merck KGaA is nearing a deal to acquire SpringWorks Therapeutics Inc., people familiar with the matter said. An announcement ...

He is the head of HHS, and yet he continues to spout untested, unproven therapies and has only given a very lukewarm ...

Such a change would put the U.S. more in line with guidance in other countries and with the World Health Organization, which ...

Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

Moderna MRNA is expected to report first-quarter 2025 earnings on May 1, before the opening bell. The company’s earnings beat ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

In the first meeting of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) ...

Peter Loftus is a reporter for The Wall Street Journal in Philadelphia covering the pharmaceutical and medical-device ...